on Theranexus (EPA:ALTHX)
Positive half-year results for Theranexus' liquidity contract
The biopharmaceutical company Theranexus has published the half-yearly report of its liquidity contract managed by Portzamparc, a BNP Paribas group company, as of June 30, 2026. The liquidity account shows 50,893 THX PHARMA shares and 112,290.14 euros.
In comparison, as of December 31, 2025, the account held 37,142 shares and €42,872.78. Since the contract came into effect in 2018, the number of shares and amounts has fluctuated, with a withdrawal of €50,000 in March 2025 and a deposit of €100,000 in February 2026.
During the first half of 2026, 221,783 shares were purchased for 708,161.86 euros and 208,032 shares were sold for 677,579.22 euros, illustrating dynamic market activity.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Theranexus news